You are partially right. But, what about the next year and the year after that? It has to be priced so low as this as the NPAT for FY17 was just $68m. Myer has a lot of fixed costs - if revenue reduces, that profit could fall dramatically.
I like the way they have moved their goalposts for the Strategy - if you aren't going to meet the target, just move the target.
Interesting times ahead with MYR.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
60.0¢ |
Change
-0.005(0.83%) |
Mkt cap ! $1.045B | |||
| Open | High | Low | Value | Volume |
| 60.0¢ | 60.5¢ | 59.8¢ | $474.3K | 790.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 51 | 378454 | 60.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.5¢ | 243265 | 32 |
View Market Depth
| Last trade - 10.42am 27/06/2025 (20 minute delay) ? |
| MYR (ASX) Chart |